# China NMPA Inspection - Xiuzheng Pharmaceutical Group Co., Ltd. - November 15, 2014

Source: https://www.globalkeysolutions.net/records/china_inspection/xiuzheng-pharmaceutical-group-co-ltd/c464292d-9704-4db9-850d-4940e60a8d90/
Source feed: China

> China NMPA unannounced inspection for Xiuzheng Pharmaceutical Group Co., Ltd. published November 15, 2014. An unannounced inspection by the State Administration for Market Regulation, in conjunction with local food and drug administrations, identified serio

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Inspection of Xiuzheng Pharmaceutical Group Co., Ltd. (Liuhe Plant)
- Company Name: Xiuzheng Pharmaceutical Group Co., Ltd.
- Publication Date: 2014-11-15
- Product Type: drugs
- Summary: An unannounced inspection by the State Administration for Market Regulation, in conjunction with local food and drug administrations, identified serious deficiencies at Xiuzheng Pharmaceutical Group Co., Ltd. (Liuhe Plant) between November 4th and 5th, 2014. The inspection focused on the production of Feining Granules. Inspectors discovered that the company was utilizing moldy and spoiled *Fanhuncao*, a medicinal herb, in its product manufacturing. A more egregious finding was the deliberate creation of false inspection reports, signifying a profound breakdown in quality assurance and regulatory adherence. These actions represent a significant violation of the *Drug Administration Law* and established Good Manufacturing Practice (GMP) regulations. As a consequence, the State Administration for Market Regulation has instructed the Jilin Provincial Administration to revoke the company's GMP certificate and impose severe penalties for its unlawful and irregular activities, emphasizing the strict enforcement of pharmaceutical quality and safety standards.

Company: https://www.globalkeysolutions.net/companies/xiuzheng-pharmaceutical-group-co-ltd/9481c864-cf19-4912-9b46-81670552486c/